華融(02799.HK)復牌翌日未止瀉 早段挫逾24%再創上市低
中國華融(02799.HK)復牌首日(5日)急挫50%報0.51元,今早(6日)未止瀉,低開14.7%報0.435元後,初段跌幅擴大,曾跌24.5%,低見0.385元再創上市低,現跌19.6%,報0.41元,成交6.64億股,涉2.755億元。
華融日前宣佈已遵守各項復牌指引;內媒昨引述華融副總裁王文傑表示,引入戰略投資者爲公司增資,對復牌後股價具有積極的意義,按每股淨資產而言,增發後的每股淨資產將由0.46元人民幣(下同)提升至0.75元,有大幅溢價,大幅增強全體股東的權益,同時充分說明5家投資者認可華融的投資價值,看好公司長期發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.